Envista Holdings Corp

NYSE:NVST

Medical - Equipment & Services

Healthcare
$23.75 +3.06%

+$0.76 today

Market cap
$3.81B
Beta
0.89
P/E (TTM)
62.0
EPS (TTM)
$0.41
52W Low $18.32High $30.42

Volume 1.92M

Average 2.94M

NVST Total Debt

Short-term and long-term borrowings combined.

Envista Holdings CorpNYSE: NVST

Total Debt · Q3 FY2026 · quarter ended Oct 2026

Total debt broadly unchanged from a year ago

Total debt stood at $1.59B at the end of Q3 FY2026, down 0.9% from a year earlier and down 0.0% from the prior quarter. Over 3 fiscal years it compounded at +1.5% a year.

Context

  • Total debt amounted to 28.3% of total assets at the end of Q3 FY2026, down 0.1 pp from a year earlier.
  • Total debt increased in 2 of the last 3 fiscal years.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -0.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterOct 2026
$1.59B-0.0% QoQ
Last fiscal yearDec 2025
$1.6B+3.2% YoY
Year agoSep 2025
$1.6B-0.9% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.9%——
1 year+3.2%——
3-year CAGR+1.5%——
5-year CAGR——
10-year CAGR——

Total Debt history

USD · from the balance sheet

Latest · FY2025
1.6B USD
Year-over-year change
+3.2%
4-year CAGR
+1.9%

Total Debt vs competitors

How NVST compares with its peers on the latest reported figures

  • NVST's Oct 2026 total debt of $1.59B is the 3rd highest of the 11 companies compared; the peer median is $210.64M.
  • Its year-over-year change of -0.9% is the 7th highest of 11, against a peer median of -0.2%.
  • Total debt amounts to 28.3% of total assets for NVST, versus a peer median of 14.7%.
NVST Competitors Peer median
Total Debt for NVST and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
XRAYDENTSPLY SIRONA Inc.Mar 2026$2.33B -3.8%+4.8%44.6%
CONConcentra Group Holdings Parent, Inc.Sep 2026$2.13B -0.5%+26.5%70.7%
NVSTEnvista Holdings CorpOct 2026$1.59B -0.9%+1.5%28.3%
ICUIICU Medical, Inc.Jun 2026$1.27B -8.5%-7.1%32.0%
RAREUltragenyx Pharmaceutical Inc.Mar 2026$1.2B +3035.4%+243.1%92.6%
ALHCAlignment Healthcare, Inc.Mar 2026$329.97M +0.1%+27.1%26.2%
GRALGRAIL, Inc.Jun 2026$91.31M +46.9%+0.7%3.2%
SUPNSupernus Pharmaceuticals, Inc.Jun 2026$40.17M +26.4%-54.8%2.8%
DYNDyne Therapeutics, Inc.Jun 2026$19.87M -83.6%-12.7%2.0%
PRVAPrivia Health Group, Inc.Jun 2026$8.73M +31.4%-6.1%0.6%
APGEApogee Therapeutics, Inc.Jun 2026$6.83M -37.0%—0.5%
Peer median (excluding NVST) $210.64M-0.2%+0.7%14.7%

Competitors are the stored peer set for NVST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.07B606.9M940M1.07B1.21B
Short-term Investments00000
Net Receivables331.9M393.5M407.5M363M429.6M
Inventory263.8M300.8M258.8M241M288.1M
Other Current Assets12.2M123.4M137.4M115.2M97.2M
Total Current Assets1.84B1.42B1.74B1.79B2.03B
Property, Plant & Equipment (Net)392.2M425.4M434.7M419.8M438.9M
Goodwill3.13B3.5B3.29B2.26B2.36B
Intangible Assets1.05B1.09B954M649.9M627.2M
Long-term Investments(160.5M)0026.4M0
Tax Assets160.5M0000
Other Non-current Assets167.8M153.7M180.5M204.2M228.1M
Total Non-current Assets4.74B5.16B4.86B3.56B3.65B
Total Assets6.57B6.59B6.61B5.35B5.68B
Account Payables185.8M228.3M179.5M174.6M191.6M
Short-term Debt456.1M510M115.3M116M0
Tax Payables48.1M42.1M39.9M58.3M0
Deferred Revenue60.1M78.9M106.4M146.5M184.8M
Other Current Liabilities406.7M265.3M277.3M407.1M376.7M
Total Current Liabilities1.21B1.24B780.8M878.7M852.6M
Long-term Debt883.4M870.7M1.4B1.28B1.45B
Deferred Tax Liabilities(5.1M)0000
Deferred Revenue (Non-current)5.1M8.6M8.4M20.3M22.4M
Other Non-current Liabilities304.2M142.7M134M119.5M139M
Total Non-current Liabilities1.31B1.14B1.65B1.54B1.72B
Total Liabilities2.52B2.38B2.43B2.42B2.57B
Common Stock1.6M1.6M1.7M1.7M1.8M
Retained Earnings466.9M731.4M631.2M(487.4M)(440.4M)
Accumulated OCI(143.5M)(225.1M)(217.2M)(371.1M)(113.2M)
Other Stockholders Equity00000
Minority Interest400K0000
Total Equity4.06B4.21B4.17B2.93B3.11B
Total Debt1.48B1.53B1.65B1.55B1.6B
Net Debt410M922.2M713.6M478.6M386M

Envista Holdings Corp

NYSE:NVST

Intrinsic Alpha fair value

Locked

Current Price

$23.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.